Trial Details

COMPLETED
Basic Information
Clinical ID c1746
Identifier NCT04567628
Trial Title Study of Relationship Between Vedolizumab Therapeutic Drug Monitoring, Biomarkers of Inflammation and Clinical Outcomes
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Inflammatory Bowel Diseases|Colitis, Ulcerative|Crohn Disease
Interventions OTHER: No Intervention
Participant Information
Sponsor Takeda
City Ontario
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2020-10-05
Primary Completion Date 2021-09-22
Completion Date 2021-09-22